Breaking through technological and cost barriers to enter markets previously out of reach, our technology can now be applied across a wider spectrum of markets. This effort showcases not only the exceptional performance of SCiB™ chemistry but also our... https://t.co/6OfITC11PW
@jay_21_ SERA. 6mill pregnancies in US assuming half use diagnostic test at $400 that is 1.2b rev opportunity in US. Nothing attributed to international opportunities. Currently a 200mm mkt cap.